Publication of a Prospectus
Released : 03-07-2023 17:00
RNS Number : 8111ECentrica PLC03 July 2023Centrica plc
3 July 2023
Publication of Base Prospectus in respect of Centrica plc's existing Euro Medium Term Note Programme
The following base prospectus (the Base Prospectus) has been approved by the Financial Conduct Authority in respect of the update of Centrica plc's Euro Medium Term Note Programme:
Centrica plc U.S.$10,000,000,000 Euro Medium Term Note Programme, dated 3 July 2023
The Base Prospectus is available for viewing by clicking on the following URL or copying it into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8111E_1-2023-7-3.pdf
A copy of the Base Prospectus will shortly be available for inspection at the National Storage Mechanism document viewing facility at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Centrica plc
Millstream
Maidenhead Road
Windsor
Berkshire SL4 5GD
Telephone: +44 1753 494165
Email: [email protected]
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
ENDS
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDPDIEASXDESDDEFA